Spots Global Cancer Trial Database for Improving Germline Testing in At-Risk Patients With Prostate Cancer
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: Improving Germline Testing in At-Risk Patients With Prostate Cancer
Official Title: IMPRINT: A Pilot Study to Improve Germline Testing in At-Risk Patients With Prostate Cancer
Study ID: NCT05470036
Conditions
Interventions
Study Description
Brief Summary: A quality improvement initiative to improve rates of germline testing among men with prostate cancer through the use of an in-clinic educational session.
Detailed Description: This is a prospective single arm quality improvement initiative for the use of a standardized educational intervention on germline testing in prostate cancer to improve the rates of germline genetic testing among patients recommended for testing. Patients who consent to the study will undergo a one-on-one education session regarding the rationale and the benefits/risks of germline testing. Following the educational session, if a patient wishes to proceed with testing, they will sign the standard consent to proceed with germline testing via a commercial assay.
Eligibility
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: MALE
Healthy Volunteers: No
Locations
University of California San Diego, La Jolla, California, United States
Contact Details
Name: Rana McKay, MD
Affiliation: UCSD
Role: PRINCIPAL_INVESTIGATOR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
